Shilanski & Associates »

Ascendis Pharma A S shares owned by Shilanski & Associates

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Shilanski & Associates from 13F filings

Historical chart of Shilanski & Associates investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Shilanski & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Shilanski & Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $259k 1.3k 198.81

More positions owned by Shilanski & Associates

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Schwab Strategic Tr Fundamental Intl (FNDF)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Invesco Exch Traded Fd Tr Ii S&p500 Hdl Vol (SPHD)
Ishares Tr Tips Bd Etf (TIP)
Spdr Series Trust Bloomberg High Y (JNK)
Spdr Series Trust Portfolio Intrmd (SPIB)
International Business Machines (IBM)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Schwab Strategic Tr Fundamental Intl (FNDC)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Altria (MO)
Exxon Mobil Corporation (XOM)

View all positions for Shilanski & Associates

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
venBio Select Advisor
FMR
Henderson Group
Lombard Odier Asset Management
Artisan Partners Limited Partnership
Capital Research and Management Company - Division 3
T. Rowe Price Investment Management
Massachusetts Financial Services
Wellington Management Company
Franklin Resources
Perceptive Advisors
Invesco
Polar Capital Holdings

View all funds holding Ascendis Pharma A S